Breaking News
Our Food Reserves Are Vanishing THE 22% SUPPLY COLLAPSE JUST HAPPENED.
Sneak peek at the new summer kitchen and butcher shop and showcasing a new survival product.
Trump abruptly kills his Strait of Hormuz toll after just one day...
Polybee and Vegetables by Bayer ink new partnership
Top Tech News
Modular Reactors To Solve Data Center Hysteria?
DeepSeek Developing In-House AI Chip In Bid To Cut Nvidia Reliance
America just took three brand-new nuclear reactors critical in thirty days, a first for any...
Your brain doesn't peak in your 20s after all: Study reveals your mind is at its sharpest betwee
Compasses, not maps: China is building a different type of AI
The Return of the Ekranoplan
Farewell, atom-smashing Large Hadron Collider
This is already starting.
The Crosley IcyBall
It's Not a Conspiracy Anymore: Med Beds Exist and Trump Knows It
FDA Gives Emergency Authorization of Hydroxychloroquine Use
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the "off-label" drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.